The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-(4-[3-(3,4-Difluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ol ID: ALA1082611
PubChem CID: 46831694
Max Phase: Preclinical
Molecular Formula: C17H19F2N3O3S
Molecular Weight: 383.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNC[C@@H](O)CCN1c2ccccc2N(c2ccc(F)c(F)c2)S1(=O)=O
Standard InChI: InChI=1S/C17H19F2N3O3S/c1-20-11-13(23)8-9-21-16-4-2-3-5-17(16)22(26(21,24)25)12-6-7-14(18)15(19)10-12/h2-7,10,13,20,23H,8-9,11H2,1H3/t13-/m0/s1
Standard InChI Key: RDRQTGHODUVHMX-ZDUSSCGKSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
16.7861 0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7849 -0.2523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4997 -0.6652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4979 0.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2133 0.5787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2136 -0.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0041 -0.5082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4924 0.1635 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.0036 0.8357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4008 -1.2283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9719 -1.9343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3688 -2.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1945 -2.6742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6216 -1.9633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2222 -1.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9000 0.8833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2042 -0.2458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4083 1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2333 1.5629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6382 2.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4631 2.2905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8680 3.0074 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6930 3.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2181 2.9918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4465 -1.9775 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.5931 -3.3965 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 2 0
15 10 1 0
7 10 1 0
5 4 2 0
8 16 2 0
6 7 1 0
8 17 2 0
7 8 1 0
9 18 1 0
8 9 1 0
18 19 1 0
9 5 1 0
19 20 1 0
4 1 1 0
20 21 1 0
5 6 1 0
21 22 1 0
10 11 2 0
22 23 1 0
20 24 1 6
11 12 1 0
14 25 1 0
2 3 1 0
13 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.42Molecular Weight (Monoisotopic): 383.1115AlogP: 2.14#Rotatable Bonds: 6Polar Surface Area: 72.88Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.92CX LogP: 1.25CX LogD: -1.19Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -0.90
References 1. O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P.. (2010) Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231)., 53 (11): [PMID:20462211 ] [10.1021/jm100053t ]